학술논문
Fixed Duration Therapy with Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone for High Risk Smoldering Multiple Myeloma-Results of the Ascent Trial
Document Type
Abstract
Author
Source
In Blood 15 November 2022 140 Supplement 1:1830-1832
Subject
Language
ISSN
0006-4971